CN Patent
CN101780036A — 丁酸氯维地平脂微球注射液及其制备方法
Assigned to WUHAN WUYAO TECHNOLOGY Co Ltd · Expires 2010-07-21 · 16y expired
What this patent protects
本发明涉及一种可静脉注射的短效降压药丁酸氯维地平的脂微球注射液及其制备方法,它由丁酸氯维地平、注射用油、乳化剂、聚乙二醇酯、药用添加剂和注射用水组成。该脂微球注射液在保证疗效的同时,能够有效控制药物释放,降低不良反应发生率。
USPTO Abstract
本发明涉及一种可静脉注射的短效降压药丁酸氯维地平的脂微球注射液及其制备方法,它由丁酸氯维地平、注射用油、乳化剂、聚乙二醇酯、药用添加剂和注射用水组成。该脂微球注射液在保证疗效的同时,能够有效控制药物释放,降低不良反应发生率。
Drugs covered by this patent
- Cleviprex (CLEVIDIPINE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.